Modern aspects of targeted prostate biopsy

Onkourologiâ

E. A. Grin’¹  S. M. Malevich²  I. N. Orlov³  A. M. Gulko⁴  D. Yu. Chernysheva⁴  S. V. Popov⁴  V. A. Neradovskiy⁴  P. V. Vyazovtsev⁴  T. M. Topuzov⁴  I. V. Sushina⁴ 

[1] I.I. Mechnikov North-West State Medical University, Ministry of Health of Russia;S.M. Kirov Military Medical Academy, Ministry of Defense of Russia;Saint-Petersburg State University;St. Luka's Clinical Hospital;

关键词: prostate biopsy;    prostate cancer;    magnetic resonance imaging;   

DOI  :  10.17650/1726-9776-2021-17-1-153-158

来源: DOAJ

【 摘 要 】

Prostate cancer (PCa) is in second place in oncological morbidity in males and is the fifth leading cause of death among the world's population. According to current world statistics, over the past 20 years there has been an increase in primary morbidity, as well as mortality from PCa. The key to diagnosing PCa is a prostate biopsy. Nevertheless, a systemic biopsy under transrectal ultrasound control is the subject of discussion and debate in oncourology, as it has significant drawbacks that affect the qualitative result of the diagnosis of PCa. Given the importance of adequate and staged PCa, various methods of targeted biopsy under magnetic resonance control have been proposed.This review will examine the main features and significance of targeted prostate biopsy, as well as the role of magnetic resonance imaging in the early diagnosis of PCa. The method of targeted biopsy of the prostate gland can improve the detection of PCa in relation to clinically significant forms. In addition, this method is extremely promising and requires further study to further improve the quality of early diagnosis of PCa, especially when selecting patients for radical surgical treatment.

【 授权许可】

Unknown